Celltrion

Celltrion Pharmaceutical last year’s operating profit of 23.6 billion won… Best performance ever

[리포트 분석] Celltrion performance this year, Rekkirona shares influenced

[약업신문]Celltrion abandons clinical trials for COVID-19 prophylactic antibody treatment

When will Celltrion’s corona treatment approval review be completed?

Progress of Celltrion Corona Antibody Treatment in Europe

Medical newspaper mobile site, Celltrion, recorded the highest performance since its inception

Celltrion last year’s sales of 1.8491 trillion won,’the largest ever’… 63.9% ↑ compared to the previous year

Celltrion, recorded the highest performance in history in the US and Europe

Celltrion, recorded the highest performance in history in the US and Europe

Celltrion chairman’s remarks “contemplating the development of a vaccine for Corona 19,” the share price is 2%

[코로나19] Celltrion treatment,’Rekironaju’, supplied a total of 151 bottles to 4 hospitals on the first day of supply

Seo Jeong-jin, Chairman of Celltrion, “Review of vaccine development in case of short supply”